IL22 and polycystic ovary syndrome: Research suggests that alterations in the gut microbiota lead to a decrease in the metabolism of glycocholic acid and tauro-ursodeoxycholic acid, resulting in reduced levels of interleukin-22 (IL-22), which is closely associated with the pathogenesis of PCOS (52).